Skip to main content
Erschienen in: Supportive Care in Cancer 8/2018

27.04.2018 | Review Article

Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer

verfasst von: Hadeel Hassan, M. Rompola, A. W. Glaser, S. E. Kinsey, R. S. Phillips

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background/objectives

Probiotics are living microorganisms that confer a health benefit on the host when administered. This systematic review and meta-analysis investigates the efficacy and safety of probiotics in adult and paediatric patients diagnosed with cancer.

Methods

A systematic review and meta-analysis was undertaken (PROSPERO registration: CRD42016050252). Randomised controlled trials (RCT), identified through screening multiple databases were included for analysis of efficacy. Non-randomised controlled trials and case reports were included for safety analysis. Outcomes included the reduction in the incidence and severity of diarrhoea, and adverse events. Where possible, data were combined for meta-analysis using a random-effects model. Planned subgroup analyses were not possible through marked heterogeneity of study characteristics.

Results

Twenty one studies (N = 2982 participants) were included for assessment of efficacy. Probiotics may reduce the incidence of diarrhoea in patients with cancer [odds ratio (OR) = 0.52, 95% confidence interval (CI) 0.34–0.78, 95% prediction interval (PI) 0.3–0.92, I-sq 36.9%, 5 studies] and the duration of pyrexia [standardised mean difference 0.39 days, 95% CI 0.35–0.43, I-sq 0.01%, 5 studies]. Twenty five studies (N = 2242) were included in the safety analysis. Five case reports showed probiotic-related bacteraemia/fungaemia/positive blood cultures. Definitions and reporting of adverse events were variable and inconsistent.

Conclusions

There remain insufficient studies to assess the true effect of probiotics in people with cancer. Meta-analysis suggests probiotics may be beneficial but further studies are still required. Improved reporting of outcomes and adverse events in clinical trials are required to improve accuracy and confidence of conclusions drawn in future updates.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Schlundt, J. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. FAO/WHO. 2012 October 2012; Available from: https://web.archive.org/web/20121022161702/http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf Schlundt, J. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. FAO/WHO. 2012 October 2012; Available from: https://​web.​archive.​org/​web/​20121022161702/​http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf
2.
Zurück zum Zitat Holzapfel WH, Haberer P, Geisen R, Björkroth J, Schillinger U (2001) Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 73(2 Suppl):365s–373sCrossRefPubMed Holzapfel WH, Haberer P, Geisen R, Björkroth J, Schillinger U (2001) Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 73(2 Suppl):365s–373sCrossRefPubMed
3.
Zurück zum Zitat Goldenberg, J.Z., et al.,(2015) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev, 22(12) Goldenberg, J.Z., et al.,(2015) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev, 22(12)
4.
Zurück zum Zitat Pammi, M. and G. Suresh, Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2017. 28(6) Pammi, M. and G. Suresh, Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2017. 28(6)
5.
Zurück zum Zitat Liu, M.M., et al.,(2017) Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials. PLoS One,12(6) Liu, M.M., et al.,(2017) Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials. PLoS One,12(6)
6.
Zurück zum Zitat Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S (1988) Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 39(4):435–437CrossRefPubMed Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S (1988) Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 39(4):435–437CrossRefPubMed
7.
Zurück zum Zitat Guarner F, Malagelada JR (2003) Role of bacteria in experimental colitis. Best Pract Res Clin Gastroenterol 17(5):793–804CrossRefPubMed Guarner F, Malagelada JR (2003) Role of bacteria in experimental colitis. Best Pract Res Clin Gastroenterol 17(5):793–804CrossRefPubMed
8.
Zurück zum Zitat Arbuckle RB, Huber SL, Zacker C (2000) The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. Oncologist 5(3):250–259CrossRefPubMed Arbuckle RB, Huber SL, Zacker C (2000) The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. Oncologist 5(3):250–259CrossRefPubMed
9.
Zurück zum Zitat Dranitsaris G, Maroun J, Shah A (2005) Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea. Can J Gastroenterol 19(2):83–87CrossRefPubMed Dranitsaris G, Maroun J, Shah A (2005) Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea. Can J Gastroenterol 19(2):83–87CrossRefPubMed
10.
Zurück zum Zitat Redman MG, Ward EJ, Phillips RS (2014) The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol 25(10):1919–1929CrossRefPubMed Redman MG, Ward EJ, Phillips RS (2014) The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol 25(10):1919–1929CrossRefPubMed
11.
Zurück zum Zitat H Hassan, M. Rompola, Bob Phillips,(2016) The efficacy and safety of probiotics in people with cancer: an updated systematic review and meta-analysis, PROSPERO H Hassan, M. Rompola, Bob Phillips,(2016) The efficacy and safety of probiotics in people with cancer: an updated systematic review and meta-analysis, PROSPERO
13.
14.
Zurück zum Zitat Dissemination, C.f.R.a(2008), Systematic Reviews: CRD's guidance for undertaking reviews in health care,University of York: CRD Dissemination, C.f.R.a(2008), Systematic Reviews: CRD's guidance for undertaking reviews in health care,University of York: CRD
15.
16.
Zurück zum Zitat Team, R,(2015) RStudio: integrated development for R. RStudio, Inc. Team, R,(2015) RStudio: integrated development for R. RStudio, Inc.
Metadaten
Titel
Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer
verfasst von
Hadeel Hassan
M. Rompola
A. W. Glaser
S. E. Kinsey
R. S. Phillips
Publikationsdatum
27.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4216-z

Weitere Artikel der Ausgabe 8/2018

Supportive Care in Cancer 8/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.